Back to search

Article

A patient-derived amyotrophic lateral sclerosis blood-brain barrier cell model reveals focused ultrasound-mediated anti-TDP-43 antibody delivery

2024-02-27

Abstract excerpt

<h4>Background</h4> Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disorder with minimally effective treatment options. An important hurdle in ALS drug development is the non-invasive therapeutic access to the motor cortex currently limited by the presence of the blood-brain barrier (BBB). Focused ultrasound and microbubble (FUS +MB ) treatment is an emerging technology that was s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8d94685f-d512-5785-bd65-8aae30fb3a6b
DOI
10.1101/2024.02.22.581567
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A patient-derived amyotrophic lateral sclerosis blood-brain barrier cell model reveals focused ultrasound-mediated anti-TDP-43 antibody deliveryDOI 10.1101/2024.02.22.581567
Select a neighboring publication to make it the new centre.